Research-backed reference

Every peptide,
decoded clearly.

Clean, structured profiles for every compound, benefits, dosing, cycles, half-life, injection route, and side effects. Ranked by effectiveness within each category.

121

Compounds

17

Categories

Ranked

By efficacy

Browse the peptide index

121 compounds

MetabolicEmerging research

5-Amino-1MQ

5-Amino-1-Methylquinolinium

  • Explored for supporting increased energy expenditure in fat cells
  • Studied for potential fat-mass reduction in obesity research models

Morning

Dose

50-150 mg

Route

Oral

Weight BlendsEmerging research

5-Amino-1MQ / SLU-PP-332 Blend

5-Amino/SLU Blend · 1MQ-SLU-PP-332 Stack

  • 5-Amino-1MQ is studied for potential effects on adipocyte metabolism and body composition
  • SLU-PP-332 is described in preclinical rodent studies as mimicking some metabolic effects of endurance exercise

Morning

Dose

25-100 mg

Route

SubQ

MuscleModerate evidence

ACE-031

ACVR2B-Fc · RAP-031

  • Documented increases in lean muscle mass in early-phase human trials
  • Broad-spectrum trapping of multiple myostatin-family ligands

Morning

Dose

0.5-3 mg

Route

SubQ

OtherWell studied

ACTH 1-39

Corticotropin · Repository Corticotropin Injection · Acthar Gel

  • Stimulates the body's own cortisol production for conditions responsive to increased glucocorticoid activity
  • First-line option for infantile spasms in many treatment guidelines

As directed by your clinician

Dose

20-80 IU

Route

IM

CognitiveEmerging research

Adamax

  • Proposed nootropic and anxiolytic effects by analogy to related Semax-family peptides
  • Discussed informally for supporting attention and stress resilience

Morning

Dose

200-600 mcg

Route

SubQ

Weight LossEmerging research

Adipotide (FTPP)

FTPP · Fat-Targeted Proapoptotic Peptide

  • Rapid, substantial fat-mass reduction reported in primate studies
  • Mechanism distinct from appetite- or incretin-based weight agents

Morning

Dose

0.5-2 mg

Route

SubQ

OtherWell studied

Afamelanotide

Scenesse

  • Increases tolerance to sunlight and visible light exposure in EPP patients
  • Reduces frequency and severity of phototoxic reactions

As directed by your clinician

Dose

16-16 mg

Route

SubQ

SkinEmerging research

AHK-Cu

  • Studied for potential effects on VEGF expression relevant to hair follicle blood supply
  • Investigated for possible influence on dermal papilla cell activity linked to hair growth cycles

Evening

Dose

1-3 mg

Route

SubQ

MetabolicEmerging research

AICAR

Acadesine · 5-Aminoimidazole-4-carboxamide ribonucleotide

  • Studied in animal models for increased fatty acid oxidation
  • Explored for potential endurance and exercise-capacity effects

~30 min before exercise

Dose

250-500 mg

Route

SubQ

GHRPEmerging research

Alexamorelin

  • GH secretion observed in preclinical research
  • Studied for gastrointestinal motility support

~30 min before bed, empty stomach

Dose

50-150 mcg

Route

SubQ

Anti-InflamModerate evidence

Alpha-MSH

Alpha-Melanocyte-Stimulating Hormone

  • Studied for broad anti-inflammatory and immunomodulatory effects
  • Explored for skin pigmentation and photoprotection research

Morning

Dose

250-1,000 mcg

Route

SubQ

Weight LossModerate evidence

AOD-9604

HGH Fragment 176-191

  • Proposed to target fat metabolism without growth hormone's effect on blood sugar
  • Studied in human phase II obesity trials

Morning, empty stomach

Dose

250-500 mcg

Route

SubQ

Weight BlendsEmerging research

AOD-9604 / MOTS-c / Tesamorelin Blend

AMT Blend · AOD/MOTS-c/Tesa Blend

  • Tesamorelin has clinical trial evidence for visceral fat reduction in a specific approved indication
  • AOD-9604 is studied for direct lipolytic activity without the broader GH-axis stimulation associated with growth hormone secretagogues

Morning, before exercise

Dose

1-3 mg

Route

SubQ

HealingEmerging research

ARA-290

Cibinetide

  • Studied for neuropathic pain reduction in diabetic patients
  • Investigated for nerve fiber density support

Morning

Dose

1,000-4,000 mcg

Route

SubQ

SkinModerate evidence

Argireline

Acetyl Hexapeptide-3

  • Studied topically for reducing the appearance of expression lines
  • Proposed to modestly dampen muscle contraction signaling without full paralysis

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

Weight LossEmerging research

BAM-15

  • Increased energy expenditure reported in animal studies
  • Resistance to diet-induced weight gain observed in preclinical models

Morning

Dose

25-100 mg

Route

Oral

OtherWell studied

Bivalirudin

Angiomax · Angiox

  • Provides effective procedural anticoagulation during PCI
  • Associated with reduced bleeding risk relative to some heparin plus GP IIb/IIIa inhibitor regimens in certain trials

As directed by your clinician

Dose

0.75-2.5 mg

Route

IV

HealingModerate evidence

BPC-157

Body Protection Compound-157

  • Studied for accelerated tendon and ligament repair in animal models
  • Investigated for gastrointestinal mucosal protection and ulcer healing

Morning, or split AM/PM

Dose

150-500 mcg

Route

SubQ

Healing BlendsWell studied

BPC-157 / TB-500 Blend

BPC-157/TB-500 Stack · Wolverine Blend

  • Supports tendon and ligament tissue repair in preclinical research
  • Associated with reduced local inflammation

Morning, or split AM/PM

Dose

250-750 mcg

Route

SubQ

Healing BlendsModerate evidence

BPC-157 15mg / TB-500 15mg Blend

High-Dose BPC/TB Blend · 30mg Recovery Vial

  • Supports tendon and ligament tissue repair in preclinical research
  • Associated with reduced local inflammation

Morning, or split AM/PM

Dose

0.3-1 mg

Route

SubQ

OtherEmerging research

Bronchogen

  • Proposed support for bronchial and respiratory tissue function in preliminary Russian research
  • Represents a short, simple peptide structure suggested to have a favorable safety profile in publications from its developers

Morning

Dose

50-200 mcg

Route

SubQ

OtherWell studied

Buserelin

Suprefact

  • Androgen suppression in prostate cancer
  • Reduction of endometriosis-related pain

As directed by your clinician

Dose

200-1,000 mcg

Route

SubQ

Weight LossModerate evidence

Cagrilintide

AM833

  • Associated with meaningful average weight loss as monotherapy in trials
  • Once-weekly dosing schedule

Weekly · same day, any time

Dose

0.3-4.5 mg

Route

SubQ

Weight LossModerate evidence

CagriSema (Cagrilintide + Semaglutide)

Cagrilintide/Semaglutide combination

  • Associated with greater average weight loss than semaglutide monotherapy in some trial comparisons
  • Combines two complementary satiety-signaling pathways

Weekly · same day, any time

Dose

0.25-2.4 mg

Route

SubQ

CognitiveWell studied

Cerebrolysin

  • Studied for supporting cognitive recovery after ischemic stroke
  • Explored as an adjunct in traumatic brain injury rehabilitation research

Morning

Dose

500-2,150 mg

Route

IM

GHRHModerate evidence

CJC-1295 (with DAC)

CJC-1295 · DAC:GRF

  • Sustained GH/IGF-1 elevation
  • Improved recovery and sleep quality

~30 min before bed, empty stomach

Dose

1,000-2,000 mcg

Route

SubQ

GHRHModerate evidence

CJC-1295 (without DAC / Mod GRF 1-29)

Mod GRF 1-29 · Modified GRF (1-29)

  • Natural pulsatile GH release
  • Improved recovery and sleep

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

GH BlendsWell studied

CJC-1295 / GHRP-2 Blend

  • Sustains elevated growth-hormone levels
  • Supports recovery

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsWell studied

CJC-1295 / GHRP-6 Blend

Bulking GH Blend

  • Stimulates a growth-hormone pulse
  • Pronounced appetite stimulation

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsWell studied

CJC-1295 / Ipamorelin Blend

CJC/Ipa Blend · GH Blend

  • Amplifies growth-hormone pulse compared with either component alone
  • Associated with improved recovery

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

SkinModerate evidence

Copper Peptide

  • Studied for supporting collagen and elastin synthesis in skin and connective tissue
  • Investigated for antioxidant and anti-inflammatory signaling properties

Evening

Dose

1-3 mg

Route

SubQ

CognitiveEmerging research

Cortagen

  • Proposed support for cortical neuron function in aging-related research
  • Explored within bioregulator theory as a tool for studying cognitive aging

Morning

Dose

1-3 mg

Route

SubQ

OtherWell studied

Degarelix

Firmagon

  • Rapid, castrate-level testosterone suppression
  • Avoids the initial tumor flare associated with GnRH agonists

As directed by your clinician

Dose

80-240 mg

Route

SubQ

CognitiveEmerging research

Dihexa

  • Preclinical models report potent effects on synapse formation at very low doses
  • Explored as a research tool for models of cognitive impairment

Morning

Dose

5-20 mcg

Route

SubQ

Cognitive BlendsEmerging research

Dihexa / Tesofensine Blend

Dihexa-Tesofensine Stack · DT Nootropic Blend

  • Tesofensine's monoamine reuptake inhibition is studied for increased alertness, motivation, and appetite suppression
  • Dihexa is studied preclinically for synaptogenesis and memory-related support

Morning

Dose

125-500 mcg

Route

SubQ

CognitiveEmerging research

DSIP (Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide

  • Studied for potential support of delta-wave (deep) sleep in some research
  • Explored for stress-modulating and anti-anxiety properties

~30 min before bed

Dose

100-300 mcg

Route

SubQ

OtherWell studied

Dulaglutide

Trulicity

  • Improves HbA1c and fasting glucose control in type 2 diabetes
  • Once-weekly dosing supports treatment adherence

Weekly · same day, any time

Dose

0.75-4.5 mg

Route

SubQ

OtherWell studied

Elcatonin

  • Inhibits osteoclast-mediated bone resorption
  • May reduce bone pain associated with osteoporosis or vertebral compression

As directed by your clinician

Dose

10-40 IU

Route

IM

SexualModerate evidence

Enclomiphene

  • Studied for raising endogenous testosterone without suppressing natural production
  • May help preserve fertility and testicular function compared to exogenous testosterone

Morning, daily

Dose

6.25-25 mg

Route

Oral

OtherWell studied

Enfuvirtide

Fuzeon · T-20

  • Provides an additional mechanism of action for HIV-1 resistant to other antiretroviral classes
  • Can help achieve viral suppression in heavily treatment-experienced patients when combined with an optimized background regimen

Twice daily, evenly spaced

Dose

45-90 mg

Route

SubQ

LongevityEmerging research

Epithalon

Epitalon

  • May support healthy circadian rhythm and sleep patterns
  • Studied for potential telomerase-related cellular effects

Before bed

Dose

5-10 mg

Route

SubQ

OtherWell studied

Exenatide

Byetta · Bydureon · Exendin-4

  • Improves post-meal and fasting glucose control in type 2 diabetes
  • Glucose-dependent mechanism carries lower intrinsic hypoglycemia risk than sulfonylureas

Before meals

Dose

5-2,000 mcg

Route

SubQ

MuscleEmerging research

Follistatin 315

FST-315 · FS315

  • Proposed systemic reduction in myostatin/activin signaling
  • Suggested support for muscle mass preservation and growth in research models

Morning

Dose

100-300 mcg

Route

SubQ

MuscleEmerging research

Follistatin 344

FST-344 · FS344

  • Proposed reduction of myostatin-mediated suppression of muscle growth
  • Suggested support for satellite cell activation and muscle repair

Morning

Dose

100-300 mcg

Route

SubQ

LongevityEmerging research

FOXO4-DRI

  • Investigated in preclinical models for selective clearance of senescent cells
  • Studied as a potential approach to reduce senescence-associated inflammatory markers

Morning

Dose

2.5-10 mg

Route

SubQ

HealingWell studied

GHK-Cu

Copper Peptide GHK-Cu

  • Studied for stimulating collagen and elastin synthesis
  • Investigated for skin firmness and wrinkle appearance support

Evening

Dose

1-3 mg

Route

SubQ

GHRPWell studied

GHRP-2

Pralmorelin · KP-102

  • Increased GH/IGF-1 output
  • Improved recovery and sleep quality

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

GHRPWell studied

GHRP-6

GH-Releasing Hexapeptide

  • Strong appetite stimulation
  • Increased GH/IGF-1 output

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

Healing BlendsModerate evidence

GLOW Blend (BPC-157 + TB-500 + GHK-Cu)

GLOW Stack · Triple Healing Blend

  • Supports soft-tissue and connective-tissue repair
  • Studied for collagen production and skin quality

Morning, or split AM/PM

Dose

300-750 mcg

Route

SubQ

LongevityWell studied

Glutathione

  • May support antioxidant defense against oxidative stress
  • Studied for a role in liver detoxification pathways

Morning

Dose

200-1,200 mg

Route

IV

OtherWell studied

Gonadorelin

Factrel · Lutrepulse · GnRH

  • Assesses pituitary-gonadal axis function diagnostically
  • Helps maintain testicular size and endogenous testosterone/sperm production during TRT

As directed by your clinician

Dose

100-500 mcg

Route

SubQ

GHRPWell studied

Hexarelin

Examorelin

  • Strong acute GH release
  • Cardioprotective effects reported in research

~30 min before bed, empty stomach

Dose

50-200 mcg

Route

SubQ

GHWell studied

HGH (Human Growth Hormone)

Somatropin

  • Studied for growth hormone deficiency treatment
  • Investigated for body composition changes, including fat reduction and lean mass support

~30 min before bed, empty stomach

Dose

2-8 IU

Route

SubQ

LongevityEmerging research

Humanin

  • Studied for potential neuroprotective effects against oxidative and beta-amyloid stress
  • Explored for roles in mitochondrial and metabolic health

Morning

Dose

1-4 mg

Route

SubQ

OtherWell studied

Icatibant

Firazyr

  • Allows rapid, self-administered treatment of acute HAE attacks outside a hospital setting
  • Directly targets the bradykinin pathway responsible for HAE swelling

As needed, during an attack

Dose

30-90 mg

Route

SubQ

MuscleEmerging research

IGF-1 DES

Des(1-3) IGF-1 · DES IGF-1

  • High potency at the IGF-1 receptor per unit dose
  • Proposed localized hypertrophic effect at the injection site

~20 min before a workout

Dose

20-60 mcg

Route

IM

MuscleEmerging research

IGF-1 LR3

Long R3 IGF-1 · LR3 IGF-1

  • Reported support for lean tissue accrual when combined with resistance training
  • Proposed enhancement of nutrient partitioning toward muscle over fat

After a workout

Dose

20-60 mcg

Route

SubQ / IM

GHRPModerate evidence

Ipamorelin

NNC 26-0161

  • Selective GH release with minimal off-target effects
  • Improved sleep quality

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

SexualModerate evidence

Kisspeptin-10

  • Studied for stimulating the hypothalamic-pituitary-gonadal axis
  • Investigated as a research tool for reproductive hormone regulation

As directed by your clinician

Dose

50-200 mcg

Route

SubQ

Healing BlendsEmerging research

KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)

KLOW Stack · Quad Healing Blend

  • Supports soft-tissue and connective-tissue repair
  • Studied for anti-inflammatory activity in preclinical gut and skin models

Morning, or split AM/PM

Dose

350-800 mcg

Route

SubQ

Anti-InflamEmerging research

KPV

  • Studied in animal models of colitis and inflammatory bowel disease
  • Explored for skin-related inflammatory conditions

Morning, or split AM/PM

Dose

200-1,000 mcg

Route

SubQ

Weight LossWell studied

L-Carnitine

Levocarnitine

  • Modest reductions in body weight and fat mass reported in meta-analyses
  • May support exercise recovery and reduce exercise-induced muscle damage

~30 min before exercise

Dose

500-2,000 mg

Route

Oral

OtherWell studied

Lanreotide

Somatuline

  • Normalizes GH and IGF-1 levels in acromegaly
  • Controls flushing and diarrhea in carcinoid/neuroendocrine tumor syndromes

As directed by your clinician

Dose

60-120 mg

Route

SubQ

SkinEmerging research

Lemon Bottle

  • Marketed for localized reduction of small subcutaneous fat deposits
  • Used in aesthetic clinic settings as a spot-treatment alternative to surgical procedures

As directed by your provider

Dose

2-6 mg

Route

SubQ

OtherWell studied

Leuprolide

Leuprorelin · Lupron · Eligard

  • Androgen deprivation therapy in advanced/metastatic prostate cancer
  • Symptom control in endometriosis and uterine fibroids

As directed by your clinician

Dose

3.75-45 mg

Route

IM

OtherWell studied

Liraglutide

Victoza · Saxenda

  • Improves glycemic control (HbA1c reduction) in type 2 diabetes
  • Promotes clinically meaningful weight loss at higher, weight-management-labeled doses

Daily · same time, any time

Dose

0.6-3 mg

Route

SubQ

Anti-InflamModerate evidence

LL-37

  • Studied for broad-spectrum antimicrobial defense
  • Explored for supportive roles in wound healing and tissue repair

Morning

Dose

50-200 mcg

Route

SubQ

SkinModerate evidence

Matrixyl

Palmitoyl Pentapeptide-4

  • Studied topically for supporting collagen I, III, and IV synthesis
  • Investigated for potential support of fibronectin and glycosaminoglycan production

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

Weight LossModerate evidence

Mazdutide

IBI362 · LY3305677

  • Associated with meaningful average weight loss in clinical trials
  • May improve glycemic control

Weekly · same day, any time

Dose

3-9 mg

Route

SubQ

SkinModerate evidence

Melanotan I

Afamelanotide (related)

  • Produces a sunless tan by boosting the skin’s own melanin
  • More pigmentation-selective than Melanotan II, with less appetite or libido effect

Before sun exposure

Dose

250-1,000 mcg

Route

SubQ

SexualModerate evidence

Melanotan II

  • Studied for stimulating melanogenesis, producing a tanning effect without prolonged UV exposure
  • Reported secondary effects on libido in some users and small studies

Evening

Dose

250-1,000 mcg

Route

SubQ

MetabolicModerate evidence

Methylene Blue

Methylthioninium Chloride

  • Explored for potential mitochondrial and cellular energy support at low doses
  • Established clinical use for methemoglobinemia at higher, medically supervised doses

Morning

Dose

5-30 mg

Route

Oral

MuscleEmerging research

MGF (Mechano Growth Factor)

IGF-1Ec · Mechano Growth Factor

  • Proposed activation of satellite cells following mechanical muscle damage
  • Suggested support for localized post-exercise muscle repair

After a workout

Dose

200-600 mcg

Route

IM

Weight LossEmerging research

MOTS-c

  • May support insulin sensitivity based on preclinical research
  • Proposed role in mitochondrial energy metabolism

~30 min before a workout

Dose

5-10 mg

Route

SubQ

MuscleEmerging research

Myostatin Inhibitor (GDF-8)

GDF-8 inhibitor

  • Proposed reduction of a key natural brake on skeletal muscle growth
  • Rationale supported by naturally occurring myostatin-deficient animal and rare human cases showing pronounced muscularity

Morning

Dose

100-300 mcg

Route

SubQ / IM

CognitiveModerate evidence

NA-Selank

N-Acetyl Selank

  • Proposed longer duration of action compared with standard Selank
  • Explored for anxiolytic effects without apparent sedation

Morning

Dose

250-750 mcg

Route

SubQ

CognitiveModerate evidence

NA-Semax

N-Acetyl Semax

  • Proposed extended duration of action compared with standard Semax
  • Explored for potential effects on attention and short-term memory

Morning

Dose

200-600 mcg

Route

SubQ

MetabolicModerate evidence

NAD+

Nicotinamide Adenine Dinucleotide

  • Supports mitochondrial ATP production as a required metabolic cofactor
  • Investigated for roles in DNA repair via PARP and sirtuin pathways

Morning

Dose

50-200 mg

Route

SubQ

OtherWell studied

Nafarelin

Synarel

  • Reduces endometriosis-associated pelvic pain
  • Suppresses premature pubertal development in central precocious puberty

As directed by your clinician

Dose

400-800 mcg

Route

Nasal

MetabolicModerate evidence

NMN (Nicotinamide Mononucleotide)

Nicotinamide Mononucleotide

  • Studied for potential support of insulin sensitivity in early human trials
  • Explored for vascular and cardiovascular metabolic markers

Morning

Dose

125-500 mg

Route

SubQ

OtherWell studied

Octreotide

Sandostatin

  • Controls growth hormone excess in acromegaly
  • Reduces flushing and diarrhea in carcinoid syndrome

As directed by your clinician

Dose

50-500 mcg

Route

SubQ

Weight LossModerate evidence

Orforglipron

LY3502970

  • Oral administration avoids the need for injections
  • Associated with meaningful average weight loss in late-stage trials

Morning, empty stomach

Dose

3-36 mg

Route

Oral

OtherWell studied

Oxytocin

Pitocin · Syntocinon

  • Induces or augments labor contractions
  • Reduces postpartum hemorrhage by promoting uterine contraction

As directed by your clinician

Dose

0.001-0.02 IU

Route

IV

OtherWell studied

Oxytocin Acetate

Oxytocin · Pitocin · Syntocinon

  • Approved and well-established for inducing or augmenting labor in obstetric care
  • Approved for controlling postpartum hemorrhage

As directed by your clinician

Dose

5-20 IU

Route

SubQ

SkinEmerging research

Palmitoyl Pentapeptide

  • Studied in topical research for supporting extracellular matrix and collagen-related signaling
  • Explored for potential roles in tissue repair processes

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

OtherWell studied

Pasireotide

Signifor

  • Reduces cortisol excess in Cushing's disease
  • Normalizes GH and IGF-1 in acromegaly

Twice daily (AM & PM)

Dose

300-900 mcg

Route

SubQ

MuscleEmerging research

PEG-MGF

Pegylated MGF

  • Proposed sustained activation of satellite cells involved in muscle repair
  • Extended systemic half-life compared with unmodified MGF

After a workout

Dose

200-600 mcg

Route

SubQ

Weight LossModerate evidence

Pemvidutide

ALT-801

  • Associated with meaningful average weight loss in early-phase trials
  • May reduce liver fat content

Weekly · same day, any time

Dose

1.2-2.4 mg

Route

SubQ

HealingEmerging research

Pentadecapeptide

PL 14736 · BPC 15

  • Studied for gastric and intestinal mucosal protection
  • Investigated for support of ulcer healing in animal models

Morning, or split AM/PM

Dose

200-500 mcg

Route

SubQ

CognitiveEmerging research

Pinealon

  • Proposed support for sleep-wake cycle regulation in preliminary research
  • Explored for antioxidant activity in central nervous system tissue

Before bed

Dose

1-3 mg

Route

SubQ

OtherEmerging research

PNC-27

  • Proposed selective cytotoxic activity against cancer cells in preclinical laboratory studies
  • Investigated mechanism distinct from conventional chemotherapy, potentially relevant to future research

As directed by your clinician

Dose

250-1,000 mcg

Route

SubQ

OtherWell studied

Pramlintide

Symlin

  • Reduces post-meal blood glucose spikes when added to mealtime insulin
  • Associated with modest reductions in body weight in clinical studies

Before meals

Dose

15-120 mcg

Route

SubQ

SexualWell studied

PT-141 (Bremelanotide)

Bremelanotide

  • Studied for supporting sexual desire and arousal in individuals with hypoactive sexual desire disorder
  • Acts via central nervous system pathways rather than vascular mechanisms

~45 min before activity

Dose

500-1,750 mcg

Route

SubQ

Weight LossModerate evidence

Retatrutide

LY3437943

  • Associated with substantial reductions in body weight in clinical trial participants
  • May improve markers of glycemic control

Weekly · same day, any time

Dose

2-12 mg

Route

SubQ

OtherWell studied

Romiplostim

Nplate

  • Increases and sustains platelet counts in chronic ITP resistant to first-line therapy
  • Reduces the need for rescue therapies (corticosteroids, immunoglobulins) in responders

Weekly · clinician-directed

Dose

1-10 mcg

Route

SubQ

OtherWell studied

Salmon Calcitonin

Miacalcin · Fortical · Calcitonin-salmon

  • Lowers elevated serum calcium in hypercalcemia of malignancy
  • Reduces bone turnover markers and can relieve bone pain in Paget's disease

As directed by your clinician

Dose

50-200 IU

Route

SubQ

CognitiveWell studied

Selank

  • Studied for anxiolytic effects without apparent sedation
  • Explored for mild nootropic effects on attention and mental stamina

Morning

Dose

250-750 mcg

Route

SubQ

Cognitive BlendsEmerging research

Selank / Semax Blend

Selank-Semax Stack · SS Cognitive Blend

  • Studied components are individually associated with reduced anxiety-like behavior (Selank) and support for memory and attention (Semax)
  • Delivered as a single combined injection rather than two separate peptides

Morning

Dose

150-600 mcg

Route

SubQ

Weight LossWell studied

Semaglutide

Ozempic · Wegovy · Rybelsus

  • Associated with significant average body-weight reduction in clinical trials
  • Improves glycemic control in type 2 diabetes

Weekly · same day, any time

Dose

0.25-2.4 mg

Route

SubQ

CognitiveWell studied

Semax

  • Associated in research with improved attention and short-term memory performance
  • Studied for potential neuroprotective effects following cerebral ischemia

Morning

Dose

200-600 mcg

Route

SubQ

GHRHWell studied

Sermorelin

GRF(1-29) · Geref

  • Restores a more natural pulsatile GH release
  • Improved sleep quality

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsWell studied

Sermorelin / GHRP-2 Blend

Classic GH Blend

  • Stimulates growth-hormone pulse via two distinct pathways
  • Long individual research history for both components

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsModerate evidence

Sermorelin / GHRP-6 / GHRP-2 Blend

Triple Secretagogue Blend

  • Stimulates a strong growth-hormone pulse
  • Associated with pronounced appetite stimulation, useful in mass-gain-oriented research contexts

~30 min before bed, empty stomach

Dose

300-700 mcg

Route

SubQ

SkinModerate evidence

Snap-8

Acetyl Octapeptide-3

  • Studied topically for reducing the appearance of forehead expression lines
  • Proposed to extend the mechanism of related peptide Argireline

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

LongevityWell studied

SS-31

Elamipretide · Bendavia · MTP-131

  • Studied for support of mitochondrial energy production under stress
  • Investigated in clinical trials for heart failure and mitochondrial myopathy

Morning, same time daily

Dose

20-60 mg

Route

SubQ

Weight LossModerate evidence

Survodutide

BI 456906

  • Associated with meaningful average weight loss in phase 2 trials
  • May reduce liver fat content in studied populations

Weekly · same day, any time

Dose

0.6-6 mg

Route

SubQ

SkinEmerging research

SYN-AKE

  • Studied topically for reducing the appearance of expression wrinkles
  • Proposed to act through a distinct receptor mechanism from botulinum toxin and other cosmetic peptides

Morning & night (topical)

Dose

2-8 mg

Route

SubQ

HealingModerate evidence

TB-500 (Thymosin Beta-4)

Thymosin Beta-4 · TB4

  • Studied for systemic wound healing support
  • Investigated for angiogenesis promotion in damaged tissue

Morning

Dose

2-5 mg

Route

SubQ

GHRHWell studied

Tesamorelin

Egrifta · TH9507

  • Clinically demonstrated reduction in visceral adipose tissue
  • Increases IGF-1

~30 min before bed, empty stomach

Dose

1-3 mg

Route

SubQ

GH BlendsModerate evidence

Tesamorelin / CJC-1295 / Ipamorelin Blend

Triple GH Blend

  • Aims to amplify and extend growth-hormone pulse coverage
  • Supports body composition research

~30 min before bed, empty stomach

Dose

1,500-3,200 mcg

Route

SubQ

GH BlendsWell studied

Tesamorelin / Ipamorelin Blend

Tesa/Ipa Blend

  • Associated with visceral fat reduction based on tesamorelin's studied effects
  • Supports body composition changes

~30 min before bed, empty stomach

Dose

1,500-3,000 mcg

Route

SubQ

GH BlendsEmerging research

Tesamorelin / MGF / Ipamorelin Blend

Tesa/MGF/Ipa Blend

  • Systemic growth-hormone axis stimulation
  • Proposed local muscle-repair signaling from the MGF component

~30 min before bed, empty stomach

Dose

1,000-2,500 mcg

Route

SubQ

Weight LossModerate evidence

Tesofensine

NS2330

  • Associated with appetite reduction and body-weight loss in early clinical trials
  • Oral administration

Morning

Dose

0.25-1 mg

Route

Oral

LongevityWell studied

Thymosin Alpha-1

Tα1 · Zadaxin

  • May support immune resilience during chronic infection or immunosuppression
  • Studied as an adjunct in some chronic viral hepatitis protocols

Morning

Dose

800-1,600 mcg

Route

SubQ

Anti-InflamModerate evidence

Thymulin

  • Studied for support of T-lymphocyte differentiation and thymic function
  • Explored in research on age-related immune decline (immunosenescence)

Morning

Dose

100-400 mcg

Route

SubQ

Weight LossWell studied

Tirzepatide

LY3298176 · Mounjaro · Zepbound

  • Associated with significant average body-weight reduction in clinical trials
  • Improves glycemic control in type 2 diabetes

Weekly · same day, any time

Dose

2.5-15 mg

Route

SubQ

OtherWell studied

Triptorelin

Decapeptyl · Trelstar · Diphereline

  • Androgen deprivation for advanced prostate cancer
  • Suppresses estrogen-driven pain in endometriosis

As directed by your clinician

Dose

3.75-22.5 mg

Route

IM

OtherModerate evidence

Vapreotide

Sanvar

  • Studied for reduction of acute variceal hemorrhage
  • Investigated for control of neuroendocrine tumor-related secretory symptoms

As directed by your clinician

Dose

50-100 mcg

Route

SubQ

Anti-InflamModerate evidence

VIP (Vasoactive Intestinal Peptide)

Vasoactive Intestinal Peptide

  • Studied in chronic inflammatory response syndrome and mold-illness protocols
  • Explored for anti-inflammatory immune modulation

As directed by your clinician

Dose

25-100 mcg

Route

SubQ

Healing BlendsModerate evidence

VIP + BPC-157 Blend

VIP/BPC Stack

  • Studied for gut-lining and mucosal support
  • Associated with broad anti-inflammatory and immune-modulating activity

Morning, or split AM/PM

Dose

200-500 mcg

Route

SubQ

OtherWell studied

Ziconotide

Prialt · SNX-111 · Omega-conotoxin MVIIA

  • Provides an opioid-free option for severe, treatment-refractory chronic pain
  • Does not appear to cause tolerance or physical dependence with continued use

As directed by your clinician

Dose

2.4-21.6 mcg

Route

IV

A perk for you

Get $20 off your first Rythm Health test

Rythm Health is the world's easiest blood test, painless at-home collection with free home pickup, 50+ biomarkers (hormones, metabolic markers & vitamin D), and AI-powered results in 72 hours. CLIA-certified, CAP-accredited and FDA-cleared. Use my link to take $20 off your first test.

At-home · free pickupResults in 72 hoursCLIA / CAP / FDA cleared
Claim $20 Off

Latest from Learn

View all →
LifeConverted

Best Ingredients - Ultimate Absorption

Educational use only. The information and calculators on this site are provided for research and educational purposes and are not medical advice, a diagnosis, a prescription, or a substitute for a licensed healthcare provider. Many compounds described are research compounds or prescription medicines not approved for general use. You must be 21 or older. Always consult a qualified clinician before making any health decision. Read the full disclaimer · Privacy Policy

© 2026 LifeConverted. All rights reserved.

For research and educational use only.

Made with by Plondo